Antirecipient helper and cytotoxic T-cell frequencies in bone marrow transplantation

Bone Marrow Transplantation

Volumn 34, Issue 3, 2004, Pages 207-213

  Kwok, J S Y ^a   Leung, A Y H ^a   Lie, A K W ^a   Lee, T L ^a   Lau, Y L ^a   Chu, P ^a   Jones, B ^a   Hawkins, B ^a   Liang, R ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Cytotoxic T lymphocytes precursor frequency; Graft versus host disease; Helper T cell precursor frequency; IFN producing cell frequency; Limiting dilution assay

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; METHOTREXATE; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIBODY PRODUCING CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL COUNT; CHILD; CHRONIC GRANULOMATOUS DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DILUTION; DISEASE SEVERITY; DONOR; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HLA MATCHING; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE COUNT; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; PROLYMPHOCYTE; RECURRENT DISEASE; RISK ASSESSMENT; SAMPLE SIZE; SEROPREVALENCE; SIBLING;

ADULT; AGED; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 4344652822     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704566     Document Type: Article

References (32)

1. Martin PJ, Hansen JA, Storb R, Thomas ED. Human marrow transplantation: an immunological perspective. Adv Immunol 1987; 40: 379-438.
2. Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313: 765-771.
3. Storb R, Thomas ED. Allogeneic bone-marrow transplantation. Immunol Rev, 1983; 71: 77-102.
4. Beatty PG, Dahlberg S, Mickelson EM et al. Probability of finding HLA-matched unrelated marrow donors. Transplantation 1988; 45: 714-718.
5. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197-204.
6. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443-447.
7. Hows J, Bradley BA, Gore S et al. Prospective evaluation of unrelated donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study. Bone Marrow Transplant 1993; 12: 371-380.
8. Hows JM, Yin JL, Marsh J et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986; 68: 1322-1328.
9. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593-602.
10. Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 1993; 119: 207-214.
11. Leung AY, Kwok J, Lie AK et al. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings. Haematologica 2001; 86: 652-656.
12. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
13. 3H]thymidine-based limiting dilution analysis to determine HTLp and CTLp frequencies for bone marrow donor selection. Bone Marrow Transplant 1997; 20: 149-155.
14. Strijbosch LW, Does RJ, Buurman WA. Computer aided design and evaluation of limiting and serial dilution experiments. Int J Biomed Comput 1988; 23: 279-290.
15. Fazekas dSG. The evaluation of limiting dilution assays. J Immunol Methods 1982; 49: R11-R23.
16. Schwarer AP, Jiang YZ, Brookes PA et al. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation. Lancet 1993; 341: 203-205.
17. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
18. Kaplan EL Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
19. Kaminski E, Sharrock C, Hows J et al. Frequency analysis of cytotoxic T lymphocyte precursors - possible relevance to HLA-matched unrelated donor bone marrow transplantation. Bone Marrow Transplant 1988; 3: 149-155.
20. Kaminski E, Hows J, Man S et al. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 1989; 48: 608-613.
21. Roelen DL, Stobbe I, Young NT et al. Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data. Hum Immunol 2001; 62: 661-667.
22. Roosnek E, Hogendijk S, Zawadynski S et al. The frequency of pretransplant donor cytotoxic T cell precursors with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings. Transplantation 1993; 56: 691-696.
23. Schwarer AP, Jiang YZ, Brookes PA et al. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation. Lancet 1993; 341: 203-205.
24. Speiser DE, Loliger CC, Siren MK, Jeannet M. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT. Br J Haematol 1996; 93: 935-939.
25. Spencer A, Szydlo RM, Brookes PA et al. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Blood 1995; 86: 3590-3597.
26. Theobald M, Nierle T, Bunjes D et al. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med 1992; 327: 1613-1617.
27. Leung AY, Kwok J, Lie AK et al. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings. Haematologica 2001; 86: 652-656.
28. Panina-Bordignon P, Corradin G, Roosnek E et al. Recognition by class II alloreactive T cells of processed determinants from human serum proteins. Science 1991; 252: 1548-1550.
29. Adams PW, Opremcak EM, Orosz CG. Limiting dilution analysis of human, tetanus-reactive helper T lymphocytes. A rapid method for the enumeration of helper T lymphocytes with specificity for soluble antigens. J Immunol Methods 1991; 142: 231-241.
30. Deacock S, Schwarer A, Batchelor R et al. A rapid limiting dilution assay for measuring frequencies of alloreactive, interleukin-2-producing T cells in humans. J Immunol Methods 1992; 147: 83-92.
31. Clouse KA, Adams PW, Orosz CG. Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals. J Clin Microbiol 1989; 27: 2316-2323.
32. van der Meer A, Wissink WM, Schattenberg AV, Joosten I. Interferon-gamma-based mixed lymphocyte culture as a selection tool for allogeneic bone marrow donors other than identical siblings. Br J Haematol 1999; 105: 340-348.